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Clearing-House Access and Benefit-Sharing Clearing-House
Conference of the Parties
Convention on Biological Diversity
European Union
Food and Agriculture Organization of the United Nations
internationally recognized certificate of compliance
International Treaty on Plant Genetic Resources for 
Food and Agriculture
multilateral system of access and benefit-sharing
mutually agreed terms
non-governmental organizations
plant genetic resources for food and agriculture
prior informed consent
Standard Material Transfer Agreement
Ad Hoc Technical Advisory Committee on the SMTA 
and multilateral system
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Article 15 CGIAR Centers
All 11 CGIAR Research Centers that host germplasm collections in CGIAR Genebanks 
(termed Article 15 Centers) have agreements with the Food and Agriculture Organization 
of the United Nations (FAO) placing these collections within the purview of the Multilateral 
System of Access and Benefit-sharing of the International Treaty on Plant Genetic 
Resources for Food and Agriculture (International Treaty). Pursuant to these agreements, 
Article 15 Centers hold and manage these collections in trust, for the benefit of humanity.
The Article 15 Centers are:















International Center for Tropical Agriculture
International Maize and Wheat Improvement Center
International Potato Center
International Center for Agricultural Research in Dry Areas
World Agroforestry Center
International Crops Research Institute for the Semi-Arid Tropics
International Institute of Tropical Agriculture
International Livestock Research Institute
International Rice Research Institute
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Introduction 
The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of 
Benefits Arising from their Utilization to the Convention on Biological Diversity (Nagoya 
Protocol) came into force in October 2014.1  As of January 2018, the Nagoya Protocol had 
one hundred and four Contracting Parties, including the European Union. The Nagoya 
Protocol deepens and extends member states’ commitments under the Convention on 
Biological Diversity (CBD) to put operable systems in place to regulate access to genetic 
resources and associated traditional knowledge, and to monitor and enforce compliance 
by users with access and benefit-sharing legislation in provider countries. It also stablishes 
an international infrastructure – the ABS Clearing-House – which is a key component of 
international monitoring and enforcement efforts.
By way of introduction, it is important to underscore that most of the CGIAR Research 
Centers’ activities related to the conservation, research and development and distribution 
of plant genetic resources are governed by the International Treaty on Plant Genetic 
Resources for Food and Agriculture (ITPGRFA) 2 and not by the Nagoya Protocol. However, 
there are some situations where the CGIAR Centers will need to comply with regional, 
national and sub-national mechanisms that implement the Nagoya Protocol, for example, 
when accessing plant genetic resources that are not available through the ITPGRFA’s 
multilateral system of access and benefit-sharing (multilateral system). As more countries 
ratify and implement the Nagoya Protocol, an increasing proportion of the genetic 
resources that the CGIAR Centers want to collect and use could be affected by access and
benefit-sharing (ABS) laws developed under the Protocol. It is also important to highlight 
that many countries have ABS laws developed prior to their ratification of the Nagoya 
Protocol, which CGIAR Centers will need to continue to comply with when collecting 
genetic resources. Over time, countries that ratify the Nagoya Protocol will revise or 
replace their existing ABS laws to reflect their commitments under the Nagoya Protocol.
These guidelines are meant to help the CGIAR Centers understand which areas of their 
plant genetic resources-related activities could be affected by the Nagoya Protocol, and 
what their options are in terms of how they can comply with the legal obligations. The 
guidelines address situations where countries have national laws in place implementing 
the Nagoya Protocol as well as situations where the countries concerned have ratified or 
acceded to the Nagoya Protocol but do not yet have national laws and systems in place to 
implement it.
As of January 2018, few countries have put systems into place to fully implement the 
Nagoya Protocol. However, many countries and regions around the world are in the 
process of developing
1 Nagoya Protocol on Access and Benefit Sharing and the Fair and Equitable Sharing of Benefits Arising from 
Their Utilization, 29 October 2012, http://www.cbd.int/abs/text/ (accessed 18 December 2017) (Nagoya 
Protocol).
2 International Treaty on Plant Genetic Resources for Food and Agriculture, 29 June 2004,
http://www.planttreaty.org/texts_en.htm (accessed 18 December 2017) (ITPGRFA).
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such systems. In the past, the CGIAR Centers have developed guidelines, 3 frequently asked
questions4 and training materials for operating under the ITPGRFA framework. 5 As the 
CGIAR Centers have gained experience over time, these guidelines have been revised and 
updated. This first edition of guidelines concerning Centers’ operations in compliance with 
the Nagoya Protocol addresses issues that have been highlighted in consultations with the 
CGIAR Centers – primarily the genebank managers and intellectual property focal points. 
These guidelines will also need to be updated on a rolling basis as the Nagoya Protocol 
becomes more widely implemented and the CGIAR Centers gain more experience 
operating in compliance with it. 6 These guidelines provide general introduction and 
guidance for Centers on relevant issues. It is understood that Centers have their own legal 
officers and access to independent legal advice to assist in addressing particular cases that
arise in their daily work.
These guidelines focus primarily on the CGIAR Centers’ access to, and distribution of, plant 
genetic resources for food and agriculture (PGRFA) and related traditional knowledge. 
Future iterations may be revised and expanded to include sections on how the Nagoya 
Protocol applies to the CGIAR Centers’ use vis-à-vis animal, insect and microbial genetic 
resources and related traditional knowledge. A new issue that will be considered by the 
Conference of the Parties (COP) to the Nagoya Protocol is benefit-sharing in relation to the 
use of digital genetic sequence information. These guidelines will be updated in the future 
to reflect the outcome of those deliberations.
Following this introduction, these guidelines are divided into five sections. The first section 
provides an overview of the relationship of the Nagoya Protocol to the ITPGRFA, the CGIAR 
Centers’ Article 15 agreements and their earlier 1994 In-Trust Agreement with the Food 
and Agriculture Organization (FAO). 7 This general overview will provide the context for 
more in-depth analysis in subsequent sections of how the Nagoya Protocol may apply to 
the CGIAR Centers and what their obligations are in those cases. The second section 
considers when the Nagoya Protocol could apply to CGIAR genebanks and breeders 
accessing new materials. The third section analyses how the CGIAR Centers’ distributions 
of PGRFA could be affected by the Nagoya Protocol. The fourth section focuses on issues 
that the CGIAR Centers need to bear in mind concerning the operation of ‘checkpoints’ 
established within countries as part of the overall monitoring and enforcement apparatus 
established 
3 System-wide Genetic Resources Programme (SGRP), Guide for the CGIAR Centers’ Use of the Standard 
Material Transfer Agreement (Bioversity International, Rome, Italy, 2009), 
http://cropgenebank.sgrp.cgiar.org/images/file/management/Guide_SMTA_updated.pdf (accessed 18 
December 2017).
4 Frequently Asked Questions on the SMTA, http://irri.org/images/downloads/smta_faq.pdf (accessed
18 December 2017).
5 G. Moore and E. Goldberg (eds), International Treaty on Plant Genetic Resources for Food and Agriculture: 
Learning Module (SGRP, Bioversity International and the Generation Challenge Program, Bioversity 
International, Rome, Italy, 2010), http://treatylearningmodule.bioversityinternational.org/ (accessed 18 
December 2017).
6 CGIAR Scientists may send queries regarding issues raised in these guidelines to GRPolicyhelpdesk@cgiar.org
7 Agreement with FAO to Place Center In-Trust Collections of Plant Genetic Resources under the Auspices of 
FAO, May 1994, http://hdl.handle.net/10947/149 (accessed 18 December 2017) (1994 InTrust Agreements).
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by the Nagoya Protocol. This section is divided into two subsections. The first subsection 
focuses on the more common scenario in which the recipients and users of materials 
received from the CGIAR Centers will need to interact with national checkpoints. In the 
second subsection, we will consider those comparatively rare situations where the CGIAR 
Centers themselves may need to submit information to national checkpoints when their 
own use of a genetic resource triggers the need to provide a national checkpoint with 
information. In these two subsections, we will, among other things, focus on how 
recipients’ due diligence requirements under EU Regulation 511/2014 implementing the
Nagoya Protocol could impact on the CGIAR genebanks and breeders as providers of 
materials.8 Finally, the fifth section considers how and when the Nagoya Protocol could 
apply to the CGIAR Centers accessing, using and distributing traditional knowledge. 
8 EU Regulation 511/2014 on Compliance Measures for Users from the Nagoya Protocol on Access to Genetic 
Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization in the Union, (2014) OJ 
L150, establishes rules governing compliance with access and benefit-sharing for genetic resources and 
traditional knowledge associated with genetic resources in accordance with the provisions of the Nagoya 
Protocol. In 2016, the European Union Commission adopted a guidance document focusing on the scope of 
application and core obligations of Regulation 511/2014. In 2017, the Commission commissioned the 
development of a series of guidance documents to help different types of genetic resource users (including 
holders of genetic resource collections, researchers and breeders) to establish whether the activities they carry 
out fall within the scope of Regulation 511/2014. These sector-specific guidance documents also aim to assist 
users of genetic resources in identifying their due diligence obligations and in concluding how these obligations 
should be met.
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1. The relationship of the Nagoya Protocol to the ITPGRFA, Article 15
agreements and the 1994 In-Trust Agreements
The objectives of the CBD and the ITPGRFA are basically identical – the conservation and
sustainable use of genetic resources, access to genetic resources and the equitable sharing 
of benefits derived from their use. However, the ABS systems that these agreements 
require their member states to implement are very different. The ITPGRFA has created the 
multilateral system whereby countries agree to use a common approach to manage and 
share the genetic resources of 64 crops and forages listed in Annex 1 of the Treaty for 
agriculture and food-related purposes. The scope of the CBD is much broader than the 
ITPGRFA, covering all genetic resources and any potential use of those genetic resources, 
except human genetic resources and genetic resources beyond countries’ jurisdictions – 
for example, in the deep sea and the Antarctic. The CBD provides for bilateral negotiation 
of ABS agreements between access seekers, and provider states and their constituents, 
subject to prior informed consent (PIC) and mutually agreed terms (MATs). Provider states 
may provide access to genetic materials for which they are the country of origin or for 
which they have acquired in accordance with the CBD. As stated above, the primary 
objective of the Nagoya Protocol is to promote the fair and equitable sharing of benefits 
derived from their utilization to support the conservation and sustainable use of 
biodiversity by extending and operationalizing the basic approach established under the 
CBD. 
The ITPGRFA explicitly recognizes and provides a mechanism to incorporate the CGIAR 
Centers into the overall ITPGRFA framework. Article 15 of the ITPGRFA invites the Centers, 
as international institutions with independent international legal personalities (created 
through their establishment agreements and reinforced by the country hosting 
agreements), to sign agreements with the Governing Body of the ITGRFA, placing their 
‘in-trust’ collections under the ITPGRFA’s framework. Eleven CGIAR Centers signed such 
agreements with the Governing Body of the ITPGRFA, undertaking to make available the 
plant genetic resources they hold in accordance with the multilateral system and 
subjecting themselves to the overall policy guidance of the Governing Body. In this way, 
most of the CGIAR Centers’ core obligations under the ITPGRFA have their source in the
international agreement they executed with the Governing Body. 
Of course, the CGIAR Centers’ operations are also affected by the extent to which the 
Contracting Parties have implemented the ITPGRFA and the multilateral system, in 
particular. For example, on the one hand, it is certainly not required by the ITPGRFA for 
countries to pass new laws (for example, legislation, executive orders and so on) as part of 
their national implementation of the multilateral system. Indeed, the countries that have 
made the most progress implementing the multilateral system to date have been able to 
do so simply by relying on the exercise of existing powers and mandates to make requisite 
decisions, such as starting to use the Standard Material Transfer Agreement (SMTA)
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when distributing materials from their national public collections.9 However, on the other 
hand, in some countries, given the highly politicized nature of genetic resource issues, 
would be providers of materials do not feel they can ‘take the risk’ to provide materials 
under the SMTA without some kind of formal back-up in the form of law confirming the 
expectation that they should do so. In such cases, the CGIAR Centers will be directly affected 
if they cannot obtain materials from the countries, even though they are (most likely) in the 
multilateral system.
The situation is very different vis-à-vis the CBD and the Nagoya Protocol. These instruments 
do not explicitly mention the CGIAR Centers or create means by which international 
organizations like the CGIAR Centers can sign agreements to subject some or all of their 
operations to the policy guidance of the COP to the CBD or the Nagoya Protocol. Thus, as 
international organizations, the CGIAR Centers are not directly subject to the Nagoya 
Protocol. Instead, all of their concrete legal obligations pursuant to the Nagoya Protocol 
arise from the implementing measures of the countries from which they want to access 
plant genetic resources and associated traditional knowledge (and, in some cases, indirectly, 
where they want to provide these resources to others or to utilize them).10 It is for this 
reason that the answer to the question: ‘what do I have to do under the Nagoya Protocol in 
this case?’ always starts with: ‘you need to look at the national law.’
There is considerable potential for coordinated, mutually supportive implementation of the 
CBD, the Nagoya Protocol and the ITPGRFA. The boundaries between the two ABS systems 
(bilateral under the CBD and the Nagoya Protocol and multilateral under the ITPGRFA) are 
relatively clear, and they do not overlap. However, there is a close relationship between the 
two agreements. For organizations like the CGIAR Centers working with PGRFA, it is 
impossible to provide meaningful guidance with respect to operating under the Nagoya 
Protocol without simultaneously considering the application of the ITPGRFA’s multilateral 
system. 
The ITPGRFA was negotiated to be in harmony with the CBD, and it is explicitly based on the 
principle underscored in the CBD that all countries have sovereign rights over their natural 
resources, including their genetic resources. The Nagoya Protocol in turn was negotiated in 
full knowledge of the ITPGRFA and the multilateral system. The CBD’s COP decision adopting 
the text of the Nagoya Protocol states that the ITPGRFA is a complementary instrument to 
the CBD and to the Nagoya Protocol. In its preamble, the Nagoya Protocol recognizes the 
ITPGRFA and recalls the existence of the multilateral system. Most importantly, while the 
ITPGRFA is not explicitly mentioned (nor is any other agreement) in Article 4 of the Nagoya 
Protocol, dealing with the ‘relationship with international 
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9 Standard Material Transfer Agreement, 16 June 2006, 
http://www.fao.org/plant-treaty/areas-ofwork/the-multilateral-system/the-smta/en/
(accessed 18 December 2017) (SMTA).
10 Some CGIAR Centers have raised questions about whether their operations as conservers and distributers of 
germplasm could be affected by systems that their host country could eventually put into place as part of their 
strategies to implement the Nagoya Protocol. In short, they should not, given the combined factors of each 
CGIAR Center’s (1) international legal personality, (2) host county agreements, (3) 1994 In-Trust Agreements, 
(4) 2006 Article 15 agreements with the ITPGRFA, (5) genebank and breeding program distributions fitting so 
squarely under the ITPGRFA framework and the fact that (6) the Nagoya Protocol recognizes (and does not 
apply to) the ITPGRFA’s Article 15 agreements and so on.
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agreements and instruments’, this article clearly recognizes, and leaves space for, the 
uninterrupted operation of the ITPGRFA, the Article 15 agreements and, even before them, 
the 1994 In-Trust Agreements. Subparagraphs 4.3 and 4.4 are the most important in this 
regard, stating:
In short, by virtue of these clauses, the CGIAR Centers’ activities that fall squarely, and 
exclusively, under the framework of the multilateral system, their 2006 agreements with 
the Governing Body under Article 15 of the ITPGRFA, and their 1994 CGIAR–FAO In-Trust 
Agreements are not (or at least should not be) affected by the Nagoya Protocol. Examples 
of such activities by the CGIAR Centers are:
The MATs under which the CGIAR Centers acquire such plant genetic resources should 
incorporate provisions for their further distribution (or the new lines into which they are 
incorporated), ideally under the SMTA (that is, to manage them under the ITPGRFA 
framework). This is consistent with the CGIAR’s mission as well as the Centers’ 
commitments to conserving, creating and providing international public goods. Sections 2, 
3, 4 and 5 of this document provide more detailed analyses of how the Nagoya Protocol 
may (or may not) apply to the CGIAR Centers’ day-to-day uses of plant genetic resources 
and traditional knowledge and the Centers’ options for complying with the letter or the 
spirit of the Nagoya Protocol when the Protocol is not fully implemented.
This Protocol shall be implemented in a mutually supportive manner with other
international instruments relevant to this Protocol. Due regard should be paid to 
useful and relevant ongoing work or practices under such international instruments 
and relevant international organizations, provided that they are supportive of and 
do not run counter to the objectives of the Convention and this Protocol.
This Protocol is the instrument for the implementation of the access and 
benefitsharing provisions of the Convention. Where a specialized international 
access and benefit-sharing instrument applies that is consistent with, and does not 
run counter to the objectives of the Convention and this Protocol, this Protocol does 
not apply for the Party or Parties to the specialized instrument in respect of the 




Distributing ‘in-trust’ germplasm using the SMTA to recipients who will use these 
materials for the purposes set out in the SMTA
Receiving plant genetic resources from the multilateral system under the SMTA.
•
•
However, as explained above, there are some activities that the CGIAR Centers engage in 
that would likely be governed by the Nagoya Protocol or the CBD. Examples of such 
activities are:
Missions to collect plant germplasm that is not included in the multilateral system
Collecting, using or distributing traditional knowledge associated with genetic 
resources
Breeding new lines that incorporate plant genetic resources accessed under national 
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2. CGIAR genebanks and breeders acquiring PGRFA
The materials that the CGIAR Centers seek to acquire may be governed under the 
ITPGRFA’s multilateral system or under national laws implementing the Nagoya Protocol. It 
is also possible that the uses for which genetic resources are sought are not regulated 
under either of the two agreements. This section is dedicated to helping the CGIAR Centers 
figure out what rules apply on a case-by-case basis and how to comply with them. The 
decision-making tree included in Annex 1 is meant to complement this section.
The CGIAR Centers acquire genetic resources of crops, forages, trees and wild relatives for 
inclusion in their genebanks and field collections and for incorporation in their breeding 
programs. They access these materials from a range of different sources in a range of 
different contexts. For example, working closely with national programs, they may 
organize or support new collecting missions to obtain materials from in situ conditions in 
farmers’ fields or protected areas. In the context of joint research and breeding programs, 
they may receive genetic resources from national agricultural research organizations, 
universities, private companies, non-governmental organizations (NGOs) and farmers and 
other private individuals. They may receive materials from national programs in the 
execution of their role as the coordinators of international crop evaluation networks (for 
example, the International Network for the Genetic Evaluation of Rice) or genomics 
research consortia (for example, the Musa Genomics Consortium). In each case, the CGIAR 
Centers need to know the national law that applies to the Centers’ acquisition of material 
and the particular terms and conditions under which they acquire it. 
Where is it possible to get information about the laws in the countries where the CGIAR
Centers would like to acquire material?
The CGIAR Centers’ first steps in making sure that their acquisitions of PGRFA are in line 
with existing ABS laws may be (1) to find out whether the given country is a party to the 
ITPGRFA, the CBD and the Nagoya Protocol; if so (2) to get in touch with the focal points 
for these international agreements and (3) to obtain information about existing ABS 
measures. To find out if the country concerned has ratified these three agreements (and, 
thus, has become a Contracting Party to the agreements), one can consult the list of 
Contracting Parties maintained by the relevant secretariats of these agreements. All 
countries except for the Holy See and the United States are parties to the CBD (the list of 
Contracting Parties to the Nagoya Protocol is available at 
https://www.cbd.int/abs/nagoyaprotocol/signatories/; the list of Contracting Parties to the 
ITPGRFA is available at http://www.planttreaty.org/content/contracting-parties-treaty). 
The Contracting Parties undertake responsibility to implement the agreements they have 
ratified
Page 15 of 38
To find out the actual state of implementation of these agreements in a country, the 
simplest thing (at least in theory) is to contact the national public authorities responsible 
for the implementation and administration of the ITPGRFA and the ABS-related provisions 
under the CBD and Nagoya Protocol (the list of national focal points under the Nagoya 
Protocol is available at https://absch.cbd.int/search/national-records/NFP; the list of 
national focal points under the ITPGRFA is available at http://www.planttreaty.org/nfp; it is 
possible (but by no means guaranteed) to obtain the text of the national laws and policies 
related to the implementation of the multilateral system through FAOLEX at 
http://faolex.fao.org/).
How can the CGIAR Centers know whether to apply for access to particular materials 
under the ITPGRFA or under the CBD and the Nagoya Protocol?
When countries that are parties to the ITPGRFA have notified the Treaty Secretariat about 
particular collections that are included in the multilateral system, the CGIAR Centers can 
safely assume that facilitated access to those collections will be provided subject to the 
SMTA for ‘utilization and conservation for research, breeding and training for food and 
agriculture’ (Article 12.3(a) of the ITPGRFA). However, for all other genetic resources, the 
CGIAR Centers, acting on their own, cannot know for sure which regime will apply. 
However, they can make informed predictions based on the basic rules of the multilateral 
system and the information they may be able to gather about the state of implementation 
of the relevant international agreements in the countries concerned. And, very 
importantly, they can check with the managers of the collections, the authorities managing 
protected areas, the high-level representatives of national programs and, ultimately, the 
national focal points. 
A lot has already been written about the scope of the multilateral system and the plant 
genetic resources that are automatically included in this system.11 Space does not permit 
repeating it here. In short, all PGRFA of the 64 crops and forages listed in Annex 1 of the 
ITPGRFA, found in a state that is a party to the Treaty and ‘under the management and 
control’ of the Contracting Party ‘and in the public domain,’ are automatically included in 
the multilateral system. The Ad Hoc Technical Advisory Committee on the SMTA and 
multilateral system (TAC SMTA) has opined that ‘under the management’ refers to a 
Contracting Party’s ‘capacity to determine how the material is handled and not to the legal 
rights to dispose of the PGRFA,’ while control refers to the ‘legal power to dispose of the 
material.’ ‘Contracting Party’ refers to national governments, not to provincial or municipal 
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11 See, for example, G Moore, W Tymowski, Explanatory Guide to the International Treaty on Plant Genetic 
Resources for Food and Agriculture, International Union for the Conservation of Nature, Gland, Switzerland, and 
Cambridge, UK, 2005; SGRP, 2009. Guide for the CGIAR Centers’ Use of the Standard Material Transfer 
Agreement. SGRP, Rome (section 2 in particular); C Correa, Plant genetic resources under the management and 
control of contracting parties and in the public domain: how rich is the ITPGRFA’s multilateral system, in M 
Halewood, I López Noriega, S Louafi, Creating a global crop commons, Routledge, New York, 2013; and M 
Halewood et al. 2018. Decision-making tool for national implementation of the Plant Treaty’s multilateral 
system of access and benefit sharing. Bioversity International, Rome.
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governments.12 The TAC SMTA and numerous commentators have stated that materials 
should be considered in the ‘public domain’ if they are not subject to intellectual property 
rights.13
Typically, Annex 1 materials in national genebanks or held by national research 
organizations would be considered to fall within this definition. However, in most 
countries, materials managed or controlled by farmers or companies would not be 
included. PGRFA can also be placed in the multilateral system by legal and natural persons 
holding that PGRFA. PGRFA in the multilateral system can be accessed for the purposes of 
research, breeding or training for food and agriculture by natural and legal persons in 
other countries that are Contracting Parties to the International Treaty and by the CGIAR 
Centers and other international institutions that have signed Article 15 agreements with 
the Governing Body of the Treaty. Based on this information, the CGIAR Centers will 
usually be able to form a fairly clear idea about whether the materials they are interested 
in accessing should be available under the multilateral system. However, ultimately, this is 
a matter that will be determined by the competent national authorities. And it is also the 
case that many countries have not yet gone through processes of confirming what 
materials are included and available through the multilateral system.
When a plant genetic resource or use of a plant genetic resource does not fall under the 
multilateral system, it will often be covered by the national laws implementing the ABS 
provisions of the CBD and the Nagoya Protocol, assuming that the country concerned has 
decided to regulate access to genetic resources under the Protocol and they have had time 
to put such measure in place (a number of European countries for example have decided 
only to implement user enforcements measures and not access regulating measures). It 
can occur that a purported use of a genetic material may not be regulated under national 
laws implementing either the ITPGRFA or the Nagoya Protocol. 
The scope of the Nagoya Protocol includes ‘utilization’ of all genetic resources (with the 
exclusion of human genetic resources and those located beyond national jurisdiction). The 
utilization of genetic resources ‘means to conduct research and development on the 
genetic and/or biochemical composition of genetic resources, including through the 
application of biotechnology’ (Article 2(c) of the Nagoya Protocol). Arguably, this scope 
covers most of the uses that the CGIAR Centers would make of the material in breeding 
programs and genebanks (bearing in mind the purposes for which materials can 
subsequently be made available under the SMTA). However, there may be cases in which it 
is not clear if the use of the germplasm by a CGIAR Center constitutes ‘utilization’ in the 
sense of the Nagoya Protocol and, therefore, if it triggers the application of access 
procedures in the provider country.  
12 Report of the First Meeting of the Ad Hoc Technical Advisory Committee on the Standard Material Transfer 
Agreement and the Multilateral System, Doc. IT/AC-SMTA-MLS 1/10/Report (18–19 January 2010), Appendix 3, 
http://www.planttreaty.org/sites/default/files/ac_smta_mls1_repe.pdf (accessed 24 October 2017).
13 Ibid. Some scholars and civil society organizations have argued that this way of defining public domain is 
based on purely Western interpretations and does not reflect indigenous peoples’ ways of managing, sharing 
and controlling biological resources. ‘Public domain’ has different meanings in different jurisdictions. The 
administrative and civil law of several countries uses the term ‘public domain’ to refer to things and goods that 
cannot be appropriated by anyone because they are for public use, such as rivers, lakes, beaches, public roads 
and for whose private use only the state can grant a permit.
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Some of the activities which may or may not constitute utilization are: observing the 
performance of particular accessions in order to evaluate the presence of certain traits and 
then decide whether to include the accessions in a breeding programme; and conducting 
studies about genetic relationships and differences between geographically separated 
populations for understating variation and distribution of traits of interest. It is likely that 
when regulating access to genetic resources and putting in place monitoring mechanisms 
under the Nagoya Protocol, countries will interpret ‘utilization’ in different ways. Some 
countries may consider these activities to be ‘utilization’ in the sense of the Nagoya 
Protocol and therefore subject to national laws on ABS, while other countries may not. 
Even if there was consensus within the COP that these activities do not constitute 
‘utilization’ as meant by the Nagoya Protocol, countries could still require PIC and MATs in 
order to grant access to genetic resources for these activities. CGIAR researchers should 
make sure that they meet access requirements of the provider countries even when they 
are not certain if they will use the genetic resources in a way that can be considered 
‘utilization’ in the sense of the Nagoya Protocol. As stressed elsewhere in this document, it 
is essential that the Centers look to the actual law of the country concerned to make sure 
they know what kinds of materials, and uses of those materials, are regulated
In this context, it is noteworthy that the guidance documents developed by the EU 
Commission for the implementation of the EU Regulation 511/2014 on compliance 
measures under the Nagoya Protocol interpret ‘utilization’ to not include a range of uses of 
PGRFA, including the direct use of seeds for planting and harvesting, taxonomy studies and 
morphological characterization.14 The sector-specific guidance documents being developed 
by the EU Commission to facilitate the implementation of the EU Regulation 511/2014 
have identified various ‘unresolved issues’ (that is, situations in which it is not clear 
whether the use of the genetic resources can be considered ‘utilization’ according to the 
Nagoya Protocol). These unresolved issues include the screening of genetic resources for 
selecting accessions with desired traits, population genetic and phylogeographic analyses 
and the use of commercial varieties. 
14 The non-binding Guidance Document on the Scope of Application and Core Obligations of Regulation no. 
511/2014 of the European Parliament and Council on the Compliance Measures for Users from the Nagoya 
Protocol, (2016) OJ C313, http://eur-lex.europa.eu/legalcontent/EN/TXT/?uri=CELEX%3A52016XC0827(01)
(accessed 18 December 2017) (EU ABS Guidelines) states that ‘[g]iven that the mere planting and harvesting of 
seeds or other reproductive material by a farmer does not involve research and development, this is outside 
the Regulation’s scope’ (at 8). The document developed under the auspices of the Food and Agriculture 
Organization’s Commission on Genetic Resources for Food and Agriculture in 2015 adopts a similar 
interpretation and states: ‘If the activities triggering access provisions are limited to “utilization” within the 
meaning of the Nagoya Protocol, certain typical uses of GRFA, for example the growing of seeds for
subsequently using the harvested products for human consumption clearly do not qualify as utilization and 
therefore do not trigger the application of access provisions.’ Elements to Facilitate Domestic Implementation 
of Access and Benefit-sharing for Different Subsectors of Genetic Resources for Food and Agriculture,’ Doc. 
CGRFA-15/15/Report (19–23 January 2015), para. 46, http://www.fao.org/3/amm660e.pdf (accessed 18 
December 2017). 
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 EU Regulation 511/2014 and its accompanying guidance documents focus entirely on 
establishing measures to monitor the ‘utilization’ of genetic resources in EU countries that
are accessed from other countries that are Parties to the Nagoya Protocol and that have 
national ABS measures in place; the EU law does not establish standards for regulating 
access to genetic resources in the EU. Again, it is important to underscore that provider 
countries benefit-sharing will interpret ‘utilization’ more broadly than the EU in order to 
encompass a broader range of uses than are included in the EU’s law. 
The CGIAR Centers will be obliged to comply with these interpretations when seeking 
access to genetic materials in these countries. However, these provisions would not be 
enforceable in the EU pursuant to the user measures they have put in place to monitor 
‘utilization.’ Thus, uses of materials in the EU that do not constitute utilization as defined 
by the EU would not be monitored by the national checkpoints. In these cases, therefore, 
users would not need to comply with (and compile and adduce evidence of) due diligence 
ascertaining that the materials they are using have been legally accessed. This does not 
mean that Centers can disregard their agreements with providers of genetic resources.
They are still legally (and morally) binding on the Center that makes the agreements. It just 
means that the monitoring and enforcement mechanisms that are put in place in the EU 
would not apply to those aspects of those agreements.
Where the regime that applies to the access request is not clear, the CGIAR Centers may 
want to make enquiries directly with the national focal points or work through national 
partner organizations who can investigate with the competent national authorities on their 
behalf. Alternatively, the CGIAR Centers can find out by simply applying for access, thereby 
setting in motion the national processes for making a determination. 
There is a long-standing tradition of informal exchanges between breeders. The 
international agreements adopted in the last decades – both the ITPGRFA and Nagoya 
Protocol – require changes to this modus operandi. Most of the time, the breeding 
materials being transferred from national programs to the CGIAR Centers will be in the 
multilateral system. However, the ITPGRFA will not always apply. Whereas researchers and 
breeders in national programs may have been able to say in the past that they had the 
ability to provide genetic resources on their own, national laws implementing the Nagoya 
Protocol will require providers to get additional sign-off from the competent national 
authorities (assuming the purposes of utilization fall within the scope of the national law).
How can the CGIAR Centers find out the process to follow to obtain access to genetic
resources in accordance with the CBD and the Nagoya Protocol? 
The Nagoya Protocol states that each party, by the time the Nagoya Protocol enters into 
force for that country, needs to appoint a national focal point and a competent national 
authority and to publicize their names and contact information through the online ABS 
Clearing-House maintained by the CBD’s Secretariat (Article 13.4 of the Nagoya Protocol). 
The national focal point is to provide applicants with ‘information on procedures for 
obtaining prior informed consent and establishing mutually agreed terms, including 
benefit-sharing’ (Article 13.1 of the Nagoya Protocol). The competent national 
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authorities are responsible for granting access and issuing written evidence that the access
requirements have been met (Article 13.2 of the Nagoya Protocol). In addition, the Nagoya 
Protocol requires parties to publish all ‘legislative, administrative and policy measures on 
access and benefitsharing’ on the ABS Clearing-House (Article 14.2 of the Nagoya 
Protocol). National ABS measures implementing the Nagoya Protocol are available at 
https://absch.cbd.int/search/national-records/MSR. Currently, 50 countries have published 
information about legal, administrative and policy measures on the ABS Clearing-House. 
Since a number of Contracting Parties have not published relevant information yet, it is 
advisable to get in touch with the national ABS focal point anyway.
In addition to addressing the actual holder of the resources, the CGIAR Centers should 
send their request for genetic resources to the competent national authorities designated 
by the countries of the Nagoya Protocol. If the names and contact details of the competent 
national authorities have not been made public, the CGIAR Centers can contact the 
national ABS focal point. Some countries may put in place processes for obtaining the PIC, 
or the approval and involvement, of indigenous peoples and local communities in the 
process to get access to genetic resources, in accordance with Article 6.3(f) of the Nagoya 
Protocol. In cases where countries have not put in place clear rules and procedures for
access seekers to get the PIC from indigenous and local communities, the CGIAR Centers, 
as a good practice, should seek the involvement of these communities and get their 
approval when collecting genetic resources that indigenous and local communities 
conserve and manage.15 Section 4 provides further guidance on how to deal with 
indigenous and local communities in the absence of national law. 
What is required under the Nagoya Protocol to get access to genetic resources?
Article 6.1 of the Nagoya Protocol (and Article 15.5 of the CBD) states that access to 
genetic resources will be subject to the PIC of the Contracting Parties, ‘unless otherwise 
determined by that Party.’ Some countries have used this flexibility and decided not to 
require PIC for access to their genetic resources – for example, the Netherlands and the 
United Kingdom. Article 6.3 of the Nagoya Protocol states that those Contracting Parties 
that require PIC as a precondition for access ‘shall take the necessary legislative, 
administrative or policy measures’ to provide legal certainty with respect to 
15 Nagoya Protocol, Article 6.2 establishes that ‘In accordance with domestic law, each Party shall take 
measures, as appropriate, with the aim of ensuring that the prior informed consent or approval and 
involvement of indigenous and local communities is obtained for access to genetic resources where they have 
the established right to grant access to such resources.’ Some experts have interpreted that this article creates 
an obligation on all parties to the Nagoya Protocol to take measures to ensure indigenous and local 
communities’ involvement in the access process. Based on this, if the CGIAR Centers want to operate in the 
spirit of the Protocol, they should always seek the approval of indigenous and local communities when 
accessing genetic resources over which those communities have rights, regardless of the existence of a national 
law (or lack of thereof) in this respect. This approach has been reflected in the Implementation Guidelines for 
the CGIAR Principles on the Management of Intellectual Assets (IA Principles) in relation to Article 3.2 of the IA 
Principles, which provides that ‘CGIAR seeks to be respectful of national and international efforts to protect and
promote farmers’ rights as envisaged by the Treaty and support the development of appropriate policies and 
procedures for their recognition and promotion.’ Implementation Guidelines for the CGIAR Principles on the 
Management of Intellectual Assets (14 June 2013),
https://cgspace.cgiar.org/bitstream/handle/10947/4487/Implementation%20Guidelines%20for%20the
%20CGIAR%20IA%20Principles.pdf (accessed 18 December 2017).
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domestic ABS rules, clearly identify who to apply for access and how and so on. That said, 
the Nagoya Protocol does not actually set out any specific procedures that need to be put 
in place in countries to receive and consider access applications. The Contracting Parties 
have considerable flexibility in this regard. Based on several provisions of the Nagoya 
Protocol (Articles 6, 13 and 17), the CGIAR Centers can expect to be requested to do the 
following:
The IRCC serves as evidence that the genetic resources that it covers have been accessed 
in accordance with PIC and that MATs have been established as required by domestic 
access and benefit-sharing legislation. It can be provided at checkpoints, described in 
Section 5 in this article, as proof that the genetic resources being utilized have been 
obtained in conformity with the national regimes on ABS. It is important to underscore 
that it is the responsibility of the country granting access to publish the information on 
access permits or their equivalent in the ABS Clearing-House. There is no mechanism for 
other entities (including CGIAR Centers) to make such reports. Another important aspect to 
bear in mind is that the IRCC is not the only document that users of genetic resources can 
submit to checkpoints. Competent national authorities may not publish IRCC for every 
access permit and material transfer agreement under their jurisdiction. In such cases, the
actual agreements entered into by Centers, or information about them, can still be 
submitted to checkpoints as proof of compliance, subject to confidentiality obligations. .
What is an internationally recognized certificate of compliance?
Once a permit is issued by the competent national authority/ies, the country providing 
access is required to publish information on the permit in the ABS Clearing-House. 
Information on a permit that is published in the ABS Clearing-House is used to constitute 
an internationally recognized certificate of compliance (IRCC) if it contains the following 
fields of information as specified in Article 17.4 of the Nagoya Protocol:
To get the PIC of the competent national authority
To agree on the terms and conditions for ABS
To demonstrate the approval of the actual provider of the genetic resource in 
question
To demonstrate the approval of, and the terms mutually agreed with, indigenous 
and local communities in case their genetic resources and related traditional 








Unique identifier of the certificate
Person or entity to whom the PIC was granted
Subject matter or genetic resources covered by the certificate
Confirmation that MATs were established
Confirmation that PIC was obtained
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Article 17.4 of the Nagoya Protocol does not prescribe to all of the fields of information 
that would ideally be included in a transfer agreement to address users’ due diligence 
obligations under the Protocol. For example, it does not include an undertaking on the part 
of providers that they have the legal right, pursuant to national laws, contractual 
obligations, and so on, to provide the material for the purposes established in the 
agreement. It is advisable that the CGIAR Centers acquiring materials under agreements 
for genetic materials (other than the SMTA under the multilateral system) require such a 
statement to be included and perhaps even some of the details about when and how the
provider legally obtained the materials being transferred. Future editions of these 
guidelines will include the text of such model clauses.
What should a CGIAR Center do if the provider country does not have the intention of
requesting PIC and MATs?
Some Contracting Parties may decide not to require PIC and MATs as preconditions for 
access to genetic resources within their territories. Users of genetic resources accessed 
from those countries may be required by national checkpoints to show that they have 
acquired the materials legally. In such cases, it is advisable that the CGIAR Centers obtain 
from the competent national authority under the Nagoya Protocol or the CBD a written 
statement clarifying that PIC was not required by law in the provider country. Of course, it 
may be difficult to get such a document in many cases. In which case, the user should be 
prepared to provide information about the state of the law in the country of collection, the 
time of collection, and so on in order to satisfy the checkpoint.
What should a CGIAR Center do if a country from which it wants to acquire materials has
ratified the CBD or the Nagoya Protocol but does not have the mechanisms in place to
regulate access to genetic resources?
This is a relatively common scenario, given how long it takes most countries to pass 
implementing measures. In countries where there are no implementing measures in place, 
the CGIAR Centers, along with all other providers or users, will remain in a legal vacuum as 
far as the Nagoya Protocol and the CBD are concerned, without defined responsibilities or 
processes to follow. In such cases, as international organizations, the CGIAR Centers should 
not stop their enquiry regarding what they can or should do under the Nagoya Protocol by 
looking at the national implementing laws. They can and should proactively seek out ways 
to fulfil the spirit of these international agreements, to the extent possible, working with 
the partner organizations in those countries, the national focal points on ABS and the 
competent national authorities.16
16 The CGIAR Centers’ commitment to operate in line with the Convention on Biological Diversity and its 
implementing instruments in regard to access and benefit-sharing is expressed in article 4.2 of the CGIAR 
Principles on the Management of Intellectual Assets, which reads as follows: “Facilitated access to Plant 
Genetic Resources for Food and Agriculture within the purview of the Treaty shall be provided in accordance 
with the Treaty and these CGIAR IA Principles. In addition, the acquisition or transfer of any other genetic 
resources by the Centers shall be conducted in accordance with all applicable laws including those 
implementing the CBD, as well as these CGIAR IA Principles.”
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What can the CGIAR Centers do if they acquire genetic materials after the entry into 
force of the CBD without the requisite flexibility to (1) distribute them using the SMTA or 
(2) use them in the CGIAR Centers’ breeding programs? 
In such cases, they have to go back and seek such permission pursuant to the national 
laws. If there are not yet laws and procedures in place, the CGIAR Centers should follow 
the approach described in the preceding sections
The CGIAR Centers distribute hundreds of thousands of samples each year from their 
genebanks and breeding programs. Pursuant to their Article 15 agreements with the 
Governing Body of the ITPGRFA, the CGIAR Centers are obliged to make Annex 1 PGRFA 
from their ‘in-trust’ collections available under the SMTA. The second session of the 
Governing Body decided that the CGIAR Centers (and other Article 15 organizations) 
should also use the SMTA to distribute non-Annex 1 materials from their collections that 
were acquired before the entry into force of the ITPGRFA. Furthermore, pursuant to Article 
6.5 of the SMTA, improved materials developed through the CGIAR breeding programs 
that incorporate materials acquired from the multilateral system (known as ‘PGRFA under 
development’ in the lexicon of the ITPGRFA) must also be made available using the SMTA.
Under what circumstances could the CGIAR Centers’ distribution of PGRFA using the 
SMTA be affected by the Nagoya Protocol?
Genebanks
When genebanks acquire new materials, they will want to be able to manage and 
distribute them under the same terms and conditions as the ‘in-trust’ materials. To this 
end, they need to make sure that they have acquire new materials under the Nagoya 
Protocol subject to MATs so that they can introduce them into their collections and 
distribute them using the SMTA. In the absence of such MATs, the genebank’s 
management and distribution of the materials in question will be subject to different terms 
and conditions, creating unsustainable administrative burdens and transaction costs.
Breeders
It is possible that future CGIAR breeders may create improved lines derived not only from 
material accessed from the multilateral system but also from material accessed subject to 
MATs under the Nagoya Protocol. It would be crucially important to ensure that the MATs 
allow the CGIAR Center concerned to make the improved lines available using the SMTA. 
Otherwise, it would not be able to distribute them at all since the MAT requirement not to 
use the SMTA for derived breeding lines would conflict with the Treaty requirement to use 
the SMTA for the same lines. If the CGIAR Center concerned cannot make such an 
agreement with providers under the CBD/Nagoya Protocol, 
3. CGIAR genebanks’ and breeders’ distributions of PGRFA
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 the Center may choose not to accept the materials.17 In this context, it is important to 
note that there is some flexibility when it comes to distributing CGIAR Center-improved 
materials than for in-trust germplasm. That is because when distributing Center-improved 
materials as PGRFA under development, the CGIAR Centers (or any provider for that 
matter) can add terms and conditions to those in the SMTA. In this way, the Center may be 
able to accommodate restrictions from the upstream providers of material.
A future revision of these guidelines will include model clauses for ABS agreements to be 
used by the CGIAR Centers to preserve the Centers’ flexibility to distribute these materials, 
or derivatives of them, under the SMTA. These model clauses can be negotiated with 
national authorities in countries where the national measures for implementing the 
Nagoya Protocol have been, or have not yet been, adopted. Articles 19 and 20 of the 
Nagoya Protocol explicitly acknowledge the role that model contractual clauses can play. 
They are also recognized in EU Regulation 511/2014 (examples of model agreements and 
contractual clauses can be found at https://www.cbd.int/abs/resources/contracts.shtml; 
codes of conduct, best practices, standards and guidelines are available at 
https://www.cbd.int/abs/instruments/default.shtml).
Under what circumstances could the Nagoya Protocol affect the CGIAR Centers’ ability to
make material available for non-ITPGRFA purposes (for example, non-food/non-feed 
purposes or direct use by farmers)?
Like any other recipient of materials under the SMTA, the CGIAR Centers are obliged to use 
such materials only for the purposes set out in the SMTA. In the event that they want to 
use materials acquired under the SMTA for other purposes, they would need to get the 
provider’s permission pursuant to the national laws implementing the CBD or the Nagoya 
Protocol. Such action will require developing a new ABS agreement. A future revision of 
these guidelines will include model clauses to include in an ABS germplasm acquisition 
agreement that would preserve the CGIAR Centers’ flexibility to distribute materials for 
non-food/feed purposes. It is not expected that the use of this instrument will become 
widespread; the SMTA provides the requisite scope for most of the CGIAR Centers’ 
purposes.
In this context, it is worth noting that the Ad Hoc Open Ended Working Group on the SMTA 
and multilateral system opined that, pursuant to their 1994 In-Trust Agreements, the 
CGIAR Centers have the discretion to make Center-improved materials and materials from 
their ‘in-trust’ collections available for agriculture-related non-food/non-feed purposes 
and for direct use by farmers.18 The CGIAR Centers may use other material transfer 
agreements for such transfers, but these agreements must preclude the uses that are 
allowed under the SMTA.
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To whom should the CGIAR Centers report their transfers of PGRFA when using the 
SMTA and when using other instruments?
Pursuant to paragraph 5.e of the SMTA, all providers, including the CGIAR Centers, must 
report their distributions of materials under the SMTA to the Secretariat of the ITPGRFA 
and through it to the Governing Body. This obligation is also set out in Article 2 of the 
CGIAR Centers’ Article 15 Agreements with the Governing Body. There is no obligation 
under the Nagoya Protocol for international organizations to report any distributions of 
genetic resources to the ABS Clearing-House nor, to date, has there been any discussion at 
the COP/Meeting of the Parties for the Nagoya Protocol about international organizations 
making voluntary reports. That said, in the context of ‘monitoring the utilization of genetic 
resources,’ the parties to the Nagoya Protocol agree to ‘[e]ncourag[e] users and providers 
of genetic resources to include provisions in mutually agreed terms to share information 
on the implementation of such terms, including through reporting requirements’ (Article 
17.1(b) of the Nagoya Protocol). It is possible, over time, that providers of materials to the 
CGIAR Centers, or the Centers themselves, will voluntarily introduce reporting terms in 
material transfer agreements under the Nagoya Protocol in response to such 
‘encouragement.’ Given the relatively early stages of implementation of the Nagoya 
Protocol around the world, this does not need appear to be a pressing issue at the time for 
the CGIAR Centers, but it should be monitored over time
17 Occasionally, the genebanks make exceptions to this general approach if the material is unique and 
threatened and likely to disappear entirely unless the genebank agrees to conserve it under ‘blackbox’
conditions – that is to say, without permission to use it in any way and without permission to distribute it either 
under the SMTA or any other instrument. In such circumstances, the genebank will likely request the provider 
periodically for permission to make it available under the SMTA.
18 Second Meeting of the Ad Hoc Advisory Technical Committee on the Standard Material Transfer Agreement 
and the Multilateral System (August 2010). See Opinions and Advice of the Ad Hoc Technical Advisory 
Committee on the Multilateral System and the Standard Material Transfer Agreement (2015), Opinion 10, 
https://www.geves.fr/wpcontent/uploads/OPINIONS_MLS_SMTA_v1.pdf
(accessed 18 December 2017).
Page 25 of 38
Guidelines on the Nagoya Protocol 
for CGIAR Research Centers
4. Interacting with national checkpoints: information needed by the
CGIAR Centers and the recipients of materials from the CGIAR Centers
Part of the agreed-to infrastructure for monitoring users’ compliance with ABS measures 
and agreements under the Nagoya Protocol is the establishment of national checkpoints. 
Article 17 states that the Contracting Parties will designate one or more checkpoints to 
‘collect or receive, as appropriate, relevant information related to prior informed consent, 
to the source of the genetic resource, to the establishment of mutually agreed terms, 
and/or to the utilization of genetic resources, as appropriate.’ The checkpoint will provide 
this information to ‘relevant national authorities, to the Party providing prior informed 
consent and to the Access and Benefit-sharing Clearing-House.’ The Nagoya Protocol is 
silent with respect to what kind of organization should be designated as a checkpoint, 
beyond stating that they ‘must be effective and should have functions relevant to’
collecting or receiving relevant information related to the issues above. Presumably, the 
Contracting Parties will appoint organizations who can collect the requisite information in 
the course of the execution of their regular functions (for example, through a patent 
application in the case of a patent office, through notification of a new sample of an exotic 
species in the case of a botanical garden, through registration of a new plant variety under 
a national seed law or through project proposals involving genetic resources in the case of 
funding agencies).19 This information will be passed onto the provider country of the 
material, which can then use the information to monitor utilization and as a basis for 
following up with the user if the national authorities of the provider country believe that 
the genetic resources are being used beyond the scope of the PIC that was granted and the 
MATs that were established. The requirements to monitor utilization are one of the 
innovations of the Nagoya Protocol so there is not yet a great deal of information or 
experience on how this will work in practice. Article 15 of the Nagoya Protocol provides 
that each party is to take the appropriate effective and proportionate legislative, 
administrative or policy measures to ensure that genetic resources utilized within its 
jurisdiction have been accessed in accordance with PIC and that the MATs have been
established as required by domestic ABS legislation and regulatory requirements in the 
provider country. It also provides that each party is to address situations of 
non-compliance. Similar requirements for traditional knowledge associated with genetic 
resources utilized in its jurisdiction are established under Article 16. Article 18 states that 
parties are to ensure that their legal systems provide opportunities to seek recourse in 
cases of disputes arising from the MATs.
19 As of January 2018, 21 countries had shared information about their national checkpoints through the ABS 
Clearing-House. The information published by some countries through the ABS Clearing House specifies when 
and how the national checkpoints require users of genetic resources to show due diligence. For example, in 
Germany, Switzerland and Spain users of genetic resources are required to submit a due diligence declaration 
to the organ of the public administration who acts as competent national authority at different stages of the 
research and development process, namely when obtaining funding and prior to commercialization of the 
resulting product. Information available in the ABS Clearing House mechanisms about other countries’ 
checkpoints does not include this level of detail and is therefore difficult to discern when and how checkpoints 
in these countries will monitor due diligence in practice. 
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Given the modus operandi of most CGIAR genebanks and breeding programs, which 
provide germplasm and improved lines to recipients who further develop and/or release 
them, it could be that CGIAR Centers will not often directly encounter, or be monitored by 
national checkpoints. Instead, depending upon the nature of the checkpoint, it could be 
that the recipients of germplasm from the CGIAR Centers will more frequently encounter 
the checkpoints – for example, patent offices, plant variety protection offices, variety 
registration authorities, national donor agencies supporting national research and 
development organizations, and so on. In the subsequent subsections, we address the
question: how can information requirements for national checkpoints affect the CGIAR 
Centers directly (on the occasions when they are monitored by checkpoints) and indirectly 
(when the recipients of materials from the Centers are monitored by a checkpoint).
Information that is needed by recipients of materials from the CGIAR Centers vis-à-vis 
national checkpoints
 For recipients of materials from the CGIAR Centers under the SMTA, what ‘status’ 
 does the SMTA have if and when they need to interact with national checkpoints?
As stated in Section 1, the Nagoya Protocol recognizes, works around and does not affect 
the operation of the multilateral system of ABS or the CGIAR Centers’ Article 15 
agreements under the ITPGRFA. As such, transfers of materials from the multilateral 
system or from Article 15 organizations – all under the SMTA – are outside the scope of 
systems to implement the Nagoya Protocol, including designated national checkpoints. 
That said, users of materials received by the CGIAR Centers under the SMTA that do 
encounter checkpoints could well be asked for information about the source of those 
materials, evidence of PIC in compliance with national laws, and so on. On the one hand, 
since the source is the multilateral system, the checkpoint system of the Nagoya Protocol 
does not apply to this material. On the other hand, unless the checkpoint understands that 
the materials were obtained under an SMTA through the multilateral system, it cannot 
know that this particular material is beyond the checkpoint’s scope of application. To that 
end, it is in the interest of the user to provide evidence that she or he received the 
material under the SMTA from a CGIAR Center (or from any other provider in the 
multilateral system or Article 15 organization), thereby assuring the checkpoint that the 
material and its use, subject to the SMTA, does not fall under the regulatory framework 
under which the checkpoint is operating. In theory, once the user provides such evidence, 
the checkpoint should not require additional assurances or information. In this way, the 
two systems are complementary and mutually supportive. 
Pursuant to the guidelines that the EU has adopted for the implementation of the Nagoya 
Protocol, plant genetic resources received under the SMTA by recipients in the EU from 
CGIAR Centers and other organizations that have signed Article 15 agreements are 
considered outside the scope of the regulation.20 European states are in the early stages of 
putting systems in place to address this situation. Some are putting in place mechanisms 
for users to declare that they have received plant genetic resources under the SMTA, 
which suffices for the purposes of the checkpoint. The checkpoint will not be required to 
have them provide any additional information to demonstrate due diligence. This is a new 
area of practice, and most countries have still not defined the information that checkpoints 
may request about plant genetic resources obtained from the multilateral system. It is
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20 EU ABS Guidelines, Section 5.2.1 states: ‘There are various scenarios under which plant genetic resources for 
food and agriculture (PGRFA) can be obtained and utilized, depending on whether the country where genetic 
resources are accessed is a Party to the Nagoya Protocol and/or to the International Treaty on Plant Genetic 
Resources for Food and Agriculture (ITPGRFA) (24), and depending on the type of use. The overview below 
describes different situations and explains the applicability of the EU ABS Regulation in each of those situations:
Out of the scope of the EU ABS Regulation 
PGRFA covered by Annex I of the ITPGRFA(25) included into its multilateral system and obtained from 
ITPGRFA Parties. Such material is covered by a specialised international instrument for access and 
benefit-sharing that is consistent with, and does not run counter to, the objectives of the Convention 
and the Nagoya Protocol (see Article 2(2) of the Regulation and p. 5 above).
Any PGRFA received under a standard material transfer agreement (SMTA) from International 
Agricultural Research Centers such as those of the Consultative Group on International Agricultural 
Research or other international institutions that have signed agreements under Article 15 of the 
ITPGRFA (26). Such material is also covered by a specialised international instrument for access and 
benefit-sharing that is consistent with and does not run counter to, the objectives of the Convention 
and the Nagoya Protocol (see Article 2(2) of the Regulation and p. 5 above).’
•
•
impossible to know at this point what kinds of information/proof of due diligence 
checkpoints may request. With this uncertainty in mind, it is advised that all CGIAR Centers 
maintain records concerning the legal status of the different materials they hold and 
distribute under the SMTA (or other transfer instrument) in order to be able to provide 
additional information if necessary for the checkpoints. It would also be a good idea for the 
CGIAR Centers, if receiving materials under an instrument other than the SMTA, to include 
an undertaking from the provider that they have the legal right to provide the material, 
taking into account the Nagoya Protocol, the CBD and so on. While the Center may not be 
under any legally binding obligation to provide such additional information, and it will 
clearly add to the transactional burden for the CGIAR Centers to do so, recipients in 
countries where checkpoints require such information will appreciate the CGIAR Centers’ 
assistance in this regard.
 For recipients of materials from the CGIAR Centers under some other instrument  
 (that is, not the SMTA), what ‘status’ does this instrument have if and when they 
 need to interact with national checkpoints?
As stated above, the CGIAR Centers may distribute Center-improved materials and 
‘in-trust’ materials for direct use and for non-food/non-feed uses. However, they must not 
use the SMTA when doing so but, instead, use other instruments. National checkpoints will 
almost certainly not be familiar with the relevant background facts, so the CGIAR Center 
will need to be prepared to provide such information in a low-transaction, efficient 
manner. To this end, one option would be to include relevant background information in 
the recital of the legal instrument used so that a checkpoint can appreciate it is material 
from an international organization that has a legal right to hold and distribute the
materials for the purposes set out in the agreements. 
Page 28 of 38
Guidelines on the Nagoya Protocol 
for CGIAR Research Centers
CGIAR Centers’ direct interaction with checkpoints
 When might a CGIAR Center have direct interaction with, or be monitored by, a 
 national checkpoint?
On occasion, as part of their strategy for ensuring the global public goods nature of their 
improved varieties and to promote their use within countries, the CGIAR Centers may 
utilize a plant genetic resource in such a way that brings them into direct contact with a 
national checkpoint. Examples of situations where this could occur include when a CGIAR 
Center:
In addition, CGIAR Centers may be required to demonstrate due diligence in other 
contexts, particularly when applying for funding to the EU Commission and possibly other 
donors and when submitting manuscripts for publication in scientific journals. Some 
journals require the authors to declare that the genetic resources that are the subject 
matter of the article have been obtained in accordance with national ABS legislation.
 What kinds of information might the CGIAR Center have to provide? 
Presumably, checkpoints will adopt approaches that are practical and do not create 
unreachable procedural requirements for genetic resource users. For example, it is unlikely 
that checkpoints will require users to show due diligence for all ancestors of an improved 
line or a released cultivar. In reality, it is likely that most of the materials used in the CGIAR 
breeding programs will not have been accessed under the Nagoya Protocol, either because 
they were accessed before the Nagoya Protocol came into force or because they came 
through the multilateral system or from other sources that are not regulated by the 
Nagoya Protocol. In those relatively rare cases where materials accessed from countries 
where the Nagoya Protocol applies, one practical approach would be to allow the CGIAR
Centers to provide a statement confirming which materials were accessed and used after 
the entry into force of the Nagoya Protocol (October 2014) and that all other incorporated 
materials predate the entry into force of the Nagoya Protocol or are under the multilateral 
system. 21 Finally, for the remaining materials, which fall under the geographical and 
temporal scope of the Nagoya Protocol, the CGIAR Center could provide the requisite 
information.
21 Should the CGIAR Centers be prepared to make statements about materials acquired after the CBD came into 
force but before the Nagoya Protocol came into force? Strictly speaking, the mechanisms that countries are 
obliged to put into place to monitor users’ due diligence are meant to apply to Nagoya-related obligations (i.e., 
genetic resources acquired after the entry into force of the Nagoya Protocol), and everything else is outside the 
scope of that monitoring. On the other hand, in order to establish that materials were acquired before the 
Nagoya Protocol came into force, it will be useful for the CGIAR Centers to provide some details about when 
they received it, from whom and under what conditions or regulatory regime.
Seeks intellectual property rights over plant genetic resources and the related 
national authority is a designated checkpoint
Seeks to include a new variety in a national variety registry pursuant to a national 
seed law and the relevant authority is a designated checkpoint
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5. CGIAR genebanks and breeders acquiring, using and transferring 
traditional knowledge associated with genetic resources 
Neither the CBD nor its Nagoya Protocol provide a definition of traditional knowledge. 22 
Several definitions can be found in the literature and in voluntary codes of conduct 
developed by international organizations, but there is not a generally accepted definition. 
Usually, traditional knowledge is understood in a general sense (embracing the content of 
the knowledge itself as well as traditional cultural expressions, including distinctive signs 
and symbols associated with traditional knowledge) or in a narrow sense (referring to 
knowledge as such, particularly, the knowledge resulting from intellectual activity in a 
traditional context, including know-how, practices, skills and innovations). The
Inter-governmental Committee on Intellectual Property and Genetic Resources, Traditional
Knowledge and Folklore of the World Intellectual Property Organization has traditionally 
adopted the narrower sense of traditional knowledge.23
The CGIAR Centers may acquire traditional knowledge through regular activities of their 
own scientists and consultants, by direct communication with traditional knowledge 
holders or through the research partners with whom CGIAR scientists work. The various 
kinds of research and development activities in which the CGIAR Centers could access and 
use traditional knowledge include:
Gathering information on genetic resources from farmers from whom they are 
collecting
Collecting information about farmers’ practices associated with the management 
and uses of particular crops and varieties, including cultivation, seed selection, seed 
storage, culinary and medicinal uses, even when they are not collecting the 
associated resources
Participating in plant variety selection and participatory plant breeding
Collaborating with farming communities for on-farm and in situ conservation of 
genetic resources
Collaborating with farming communities for the establishment and management of 
community seed banks
Organizing, and participating in, seed fairs 
Preparing audio/visual recordings and publications pertaining to indigenous 









22 CBD, Article 8(j) refers to ‘knowledge … of indigenous and local communities embodying traditional lifestyles 
relevant for the conservation and sustainable use of biological diversity.’ This is the citation used in the recital 
to the Nagoya Protocol.
23 Intergovernmental Committee on Intellectual Property, Genetic Resources, Traditional Knowledge and 
Folklore, List and Brief Technical Explanation of Various Forms in Which Traditional Knowledge May Be Found 
(Secretariat of the Seventeenth Session of the Intergovernmental Committee, Geneva, 6–10 December 2010). 
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What are the CGIAR Centers’ obligations generally under the CBD and, more recently, the
Nagoya Protocol when seeking to access and use traditional knowledge associated with
genetic resources?
Article 7 of the Nagoya Protocol requests the parties to take measures in accordance with 
domestic law and, as appropriate, to ensure that traditional knowledge associated with 
genetic resources that is held by indigenous peoples and local communities is accessed 
with PIC or the approval and involvement of these indigenous and local communities and 
that MATs have been established. According to Article 5.5 of the Nagoya Protocol, the 
parties commit to take measures ‘in order that the benefits arising from the utilization of 
traditional knowledge associated with genetic resources are shared in a fair and equitable 
way with indigenous and local communities holding such knowledge.’ And Article 12 
states: 
Based on these three articles, the CGIAR Centers, working in countries where the Nagoya 
Protocol provisions on traditional knowledge have been implemented, can expect to be 
requested to get PIC from the farmers who share their traditional knowledge, to agree on 
MATs with them and to share the benefits arising from the use of traditional knowledge 
with the traditional knowledge providers. It may also be that community protocols have 
been established with which the CGIAR Centers will need to comply. It is also possible that 
the customary laws will apply.
In implementing their obligations under this Protocol, Parties shall in accordance 
with domestic law take into consideration indigenous and local communities’ 
customary laws, community protocols and procedures, as applicable, with respect 
to traditional knowledge associated with genetic resources.
Parties, with the effective participation of the indigenous and local communities
concerned, shall establish mechanisms to inform potential users of traditional 
knowledge associated with genetic resources about their obligations, including 
measures as made available through the Access and Benefit-sharing Clearing-House 
for access to and fair and equitable sharing of benefits arising from the utilization of 
such knowledge.
Parties shall endeavour to support, as appropriate, the development by indigenous 




Community protocols in relation to access to traditional knowledge associated 
with genetic resources and the fair and equitable sharing of benefits arising out 
of the utilization of such knowledge;
Minimum requirements for mutually agreed terms to secure the fair and 
equitable sharing of benefits arising from the utilization of traditional 
knowledge associated with genetic resources; and
Model contractual clauses for benefit-sharing arising from the utilization of 
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Both the CBD and the Nagoya Protocol are agreements between states; they create rights 
and obligations for countries that are parties to them, and they are not of themselves 
binding upon the CGIAR Centers. Thus, as stated in Section 1, the concrete legal obligations 
for the Centers come from the national laws implementing these agreements. 
How can the CGIAR Centers ascertain their specific obligations with respect to traditional
knowledge and the Nagoya Protocol in particular countries?
Under the Nagoya Protocol, countries are required to make available information to the 
ABS ClearingHouse on relevant national legislation on ABS. This information will not always 
be up to date and, in many cases, may be incomplete due to the wide body of overlapping 
laws, policies and regulations associated with traditional knowledge. This is particularly 
true for the customary laws of indigenous peoples and local communities, which may be 
held only in oral form. To find out more about the obligations concerning access to 
traditional knowledge, the CGIAR Centers should make contact with the national focal 
points and, if necessary or appropriate, with the national and/or regional experts on ABS, 
the relevant indigenous and local community representative organizations and/or the 
NGOs working closely with these communities. 
What if there is no national law implementing the Nagoya Protocol, or there is one, but it 
does not establish standards for accessing traditional knowledge?
In the absence of national law regulating access to traditional knowledge, the CGIAR 
Centers do not have any legal obligation under the Nagoya Protocol. Of course, there may 
be other laws in the country that establish standards, procedures and/or prohibitions with 
respect to accessing and using traditional knowledge. These could be laws put into place to 
implement other relevant international conventions or declarations such as the UN 
Declaration on the Rights of Indigenous Peoples and the Convention Concerning 
Indigenous and Tribal Peoples in Independent Countries, which were adopted under the 
auspices of the International Labour Organization, wherein the rights of indigenous 
peoples and local communities with respect to natural resources, and genetic resources, in 
particular, are recognized in various levels of particularity.24
24 UN Declaration on the Rights of Indigenous Peoples, 12 September 2007, UN Doc. A/61/L.67/Annex (2007), 
Article 26 recognizes indigenous peoples’ rights over their resources in general. Article 31 states that 
‘Indigenous peoples have the right to maintain, control, protect and develop their cultural heritage, traditional 
knowledge and traditional cultural expressions, as well as the manifestations of their sciences, technologies and 
cultures, including human and genetic resources, seeds, medicines, knowledge of the properties of fauna and 
flora, oral traditions, literatures, designs, sports and traditional games and visual and performing arts. They also 
have the right to maintain, control, protect and develop their intellectual property over such cultural heritage,
traditional knowledge, and traditional cultural expressions.’ Article 32 establishes that ‘[s]tates shall consult 
and cooperate in good faith with the indigenous peoples concerned through their own representative 
institutions in order to obtain their free and informed consent prior to the approval of any project affecting 
their lands or territories and other resources, particularly in connection with the development, utilization or 
exploitation of mineral, water or other resources.’ ILO Convention no. 169 Concerning Indigenous and Tribal 
Peoples in Independent Countries, 27 June 1989, 28 ILM 1382 (1989), Article 15 states that the rights of the 
peoples concerned to the natural resources pertaining to their lands shall be specially safeguarded, and that 
these rights include the right to participate in the use, management and conservation of these resources.
25 CGIAR Principles on the Management of Intellectual Assets, 7 March 2012,
http://hdl.handle.net/10947/4486 (accessed 18 December 2017).
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Or there may be customary laws of indigenous peoples and local communities themselves 
that are relevant. In some countries, national laws recognize or create space for the 
operation of such customary laws. In other countries, these laws are not formally 
recognized, but the indigenous people or local communities concerned may nonetheless 
insist that the CGIAR Centers recognize them and make their ABS arrangements 
accordingly. Of course, these protocols will have to be consistent with the national laws of 
the country concerned. In situations where there appears to be a conflict between the two 
legal systems, the CGIAR Centers should try to work with both the local communities and 
competent national authorities for a mutually satisfactory process and agreement. 
Ultimately, if this is not possible, the Center may need to discontinue efforts to access the 
genetic resources or traditional knowledge concerned.
Furthermore, in the absence of any concrete obligations defined by national laws (and/or 
customary laws), as part of its overall research ethics, CGIAR is committed to operate with 
respect to internationally accepted principles and standards in relation to using traditional 
knowledge related to genetic resources and, more generally, working with indigenous 
peoples and local communities. These standards are generally established in the 
international human rights instruments referred to above as well as in the Nagoya 
Protocol, the CBD and the ITPGRFA. They are also established in the research and ethics 
protocols that have been developed by research communities, including CGIAR.
This commitment by CGIAR to observe international principles and standards has been 
reflected in Article 3.2 of the CGIAR Principles on the Management of Intellectual Assets, 
which provide that ‘the CGIAR seeks to be respectful of national and international efforts 
to protect and promote farmers’ rights as envisaged by the Treaty and support the 
development of appropriate policies and procedures for their recognition and promotion.’
25 With respect to situations where concrete legal obligations are not in force in certain 
countries, the Implementation Guidelines for the CGIAR Principles on the Management of 
Intellectual Assets states that the CGIAR Centers should, when appropriate: 
When accessing PGRFA and/or associated traditional knowledge in the absence of
access and benefit-sharing laws, ensuring that the prior informed consent of 
farmers providing them has been given. This implies taking into account 
community protocols, if any, and proactively engaging the farmers to ensure that 
they understand the proposed uses of the PGRFA and/or the knowledge collected. 
This can be done with or through partners in the national agricultural research 
systems or other organizations with whom work is being carried out and, where 
possible, drafting written agreements that reflect their prior informed consent and 
mutually agreed terms. 26
26 Implementation Guidelines for the CGIAR Principles on the Management of Intellectual Assets, 14 June 2013, 
https://cgspace.cgiar.org/bitstream/handle/10947/4487/Implementation%20Guidelines%20for%20the
%20CGIAR%20IA%20Principles.pdf?sequence=1 (accessed 18 December 2017).
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The Guidelines include other practical actions that the CGIAR Centers could take, where 
appropriate, including:
1. These very same standards are included in a number of research ethics guidelines.27 
Perhaps the one that is most immediately relevant is the Code of Ethical Conduct to Ensure 
Respect for the Cultural and Intellectual Heritage of Indigenous and Local Communities 
Relevant to the Conservation and Sustainable Use of Biological Diversity, which was 
approved by the COP to the CBD in 2010.28 It includes recommendations on ethical 
principles to be observed and methodological aspects to be taken into consideration.29 
Since the Code of Conduct was inspired by the CBD, was a result of the CBD’s programme of 
work on Article 8(j) and was approved by the CBD’s COP, it represents a reliable
reference for the CGIAR Centers to guide their actions in the absence of applicable national 
law. In addition, the programme of work on Article 8(j) led to the development and 
adoption (in COP-13 in 2016) of voluntary guidelines for the development of mechanisms to 
ensure the PIC of indigenous peoples and local communities and other aspects involved in 
ABS.30 While these guidelines do not apply to traditional knowledge associated with genetic 
resources under the Nagoya Protocol (as stated in paragraph 5 of the guidelines) Centers 
can use then as a reference when adopting measures for ensuring the PIC and agreeing on 
MATs with farmers and other local users in countries where the Nagoya Protocol is not 
implemented. Another useful reference is the FAO Manual for Project Practitioners entitled 
Free Prior and Informed Consent: An indigenous peoples’ right and a good practice for local 
communities. 31
Proactively engaging farmers to ensure that they understand the proposed uses of 
the PGRFA and the knowledge collected
Ensuring that research results are shared with the farmers from whom the PGRFA or
associated information was accessed
Ensuring that publications referring to traditional knowledge give all appropriate 
credits to the holders/providers of such knowledge and disclose the source of such 
knowledge





27 Some of these guidelines can be found on Access and Benefit Sharing Clearing House: CBD,
https://absch.cbd.int/search/referenceRecords?schema=modelContractualClause (accessed 18 December 2017).
28 Code of Ethical Conduct to Ensure Respect for the Cultural and Intellectual Heritage of Indigenous and Local 
Communities Relevant to the Conservation and Sustainable Use of Biological Diversity (2011), 
https://www.cbd.int/doc/publications/ethicalconduct-brochure-en.pdf (accessed 18 December 2017).
29 The code of conduct provisions on ethical principles refer to: respect for existing settlements, intellectual 
property, non-discrimination, transparency/full disclosure, prior informed consent and/or approval and 
involvement, inter-cultural respect, safeguarding collective and individual ownership, fair and equitable sharing 
of benefits, protection, precautionary approach, recognition of sacred sites, access to traditional resources, not 
being arbitrarily removed and relocated, traditional guardianship/custodianship, recognition of indigenous and 
local community social structures, restitution and/or compensation, repatriation of genetic resources and 
traditional knowledge, peaceful relations and supporting research initiatives of indigenous and local 
communities
30 Mo’otz kuxtal voluntary guidelines. Available at https://www.cbd.int/doc/decisions/cop-13/cop-13-
dec-18-en.pdf
31 FAO. 2016. Free Prior and Informed Consent: An indigenous peoples’ right and a good practice for local 
communities. Manual for Project Practitioners. FAO, Rome. Available at:
http://www.fao.org/documents/card/en/c/5202ca4e-e27e-4afa-84e2-b08f8181e8c9/ (last accessed 16
January 2018)
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What practical measures can the CGIAR Centers take?
Based on all the above information, there are three basic measures that the CGIAR Centers 
should take to ensure that they are operating in line with the internationally recognized 
principles of those countries where ABS obligations are not defined by the existing legal 
regimes:
The CGIAR Centers can also take these three measures into those countries where there 
are national laws in place and where the adoption of these measures by the CGIAR Centers 
will not contradict the existing laws
The CGIAR Centers will have to approach these tasks in a practical and realistic way, 
depending on the history of collaboration with the communities providing the traditional 
knowledge and the context in which the exchange of information between scientists and 
farmers has taken place. The efforts by the CGIAR Centers to get the approval of the 
providers of traditional knowledge and to agree with them on possible conditions limiting 
the use of traditional knowledge should concentrate on research activities where scientists 
are obtaining information from farmers and farmers’ communities within a formal 
research context, such as household surveys, focus group discussions, roundtables,
workshops and so on. 
Before farmers start sharing information with scientists, the scientists should follow a 
protocol to ensure that the farmers are fully informed and understand (1) what the 
scientists propose to do with the information they will receive; (2) what benefits the 
scientists are proposing to share and (3) that the famer can refuse to share his or her 
knowledge or do so subject to conditions suggested by the farmers. For the purposes of 
demonstrating that internationally recognized principles and standards have been 
followed, the process of obtaining the farmers’ approval should result, ideally, in a
document signed by the providers of the information. If obtaining the providers’ signature 
is not viable or appropriate, scientists’ written account of the process may be enough to 
show due diligence in the absence of procedures defined or required by national law. 
Similarly, the CGIAR Centers may need to take into consideration the practical challenges 
involved in sharing the results of the CGIAR Centers’ research and development activities 
with the providers of traditional knowledge and take measures to address those 
challenges. For example, if financial limitations do not allow the CGIAR Centers’ scientists 
to organize feedback workshops and roundtables with farming communities, give them 
seeds of improved lines or distribute farmer-friendly publications at the end of a research 
project where the knowledge of those farmers has been used, the CGIAR Centers can 
explore ways for their national partners to facilitate, or take care of, these actions and/or 
adopt less resource-consuming, but still effective, measures to compensate farming
communities. 
Obtaining the approval of the providers of traditional knowledge
Agreeing with them on the conditions that apply to the use of that knowledge
Sharing the benefits, including research and development results, with the providers 
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Does the Nagoya Protocol apply the same monitoring measures to the utilization of 
genetic resources and traditional knowledge related to genetic resources?
The Nagoya Protocol treats genetic resources and associated traditional knowledge 
differently. According to Article 6 of the Protocol, Contracting Parties that regulate access 
to genetic resources are obliged to provide for a clear and transparent written decision by 
a competent national authority. If the decision is to grant access to the resources, the 
Contracting Parties must issue a permit as evidence of PIC and MATs. In the case of access 
to traditional knowledge, the Nagoya Protocol does not require countries to issue any 
official permit. However, some countries do require and issue permits for access to 
traditional knowledge. 
Article 17 of the Nagoya Protocol on ‘monitoring the utilization of genetic resources’ limits 
the monitoring mechanisms of the Protocol to genetic resources. This means that 
internationally recognized certificates of compliance do not have to be issued to users of 
traditional knowledge in order to provide proof that they have obtained such knowledge in 
accordance with the domestic laws. It also means that when establishing national 
checkpoints countries do not have to include the utilization of traditional knowledge in the 
scope of their functions (but they can, if they wish to do so).
Article 16 of the Nagoya Protocol on ‘compliance with domestic legislation or regulatory 
requirements on access and benefit-sharing for traditional knowledge associated with 
genetic resources’ does not require countries to put into place any particular monitoring 
mechanism but simply requires them to take measures ‘to provide that traditional 
knowledge associated with genetic resources utilized within their jurisdiction has been 
accessed in accordance with prior informed consent or approval and involvement of 
indigenous and local communities, as required by domestic access and benefit-sharing
laws or regulatory requirements of the other Party where such indigenous and local 
communities are located.’ Countries are therefore free to decide whether or not to 
establish checkpoints for monitoring the use of traditional knowledge. They have no such 
flexibility with respect to genetic resources, for which checkpoints must be established. If 
they wish, countries can apply similar, or the same, monitoring measures to both genetic 
resources and traditional knowledge, therefore requesting designated checkpoints to 
collect information on the origin and use of traditional knowledge, but, according to the 
Nagoya Protocol, they are not obliged to do so. The modus operandi of these possible 
checkpoints, such as patent and plant variety protection offices and funding agencies, will 
probably reflect this differentiated treatment in many countries that have ratified the 
Nagoya Protocol but not necessarily in all of them.32
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What are the CGIAR Centers’ obligations when transferring traditional knowledge 
associated with genetic resources?
The CGIAR Centers are obliged to respect the terms and conditions under which they have 
received the traditional knowledge. If the traditional knowledge accessed by a CGIAR 
Center is subject to restrictions, then it cannot be included in the information to which 
links are provided in the SMTA. Arguably, the situation is different if the genetic resources 
are transferred under the SMTA as PGRFA under development. In this case, there may be 
sufficient flexibility for the Center to pass on restrictions from the original traditional 
knowledge provider over the subsequent recipients’ use of the related traditional 
knowledge. Of course, the original traditional knowledge provider would need to have 
agreed for the CGIAR Center to pass on the traditional knowledge in this way as one of the
MATs. 
32 For example, Decision 486 of the Comunidad Andina de Naciones requests patent offices of Andean countries 
to collect information about the origin and circumstances of access to both genetic resources and traditional 
knowledge used in inventions described in patent applications and states that patent applications should be 
refused if the applicant does not present an appropriate access contract or the respective license or 
authorization for the use of traditional knowledge. However, this is a pre-Nagoya Protocol measure. In Peru, 
the implementing legislation of the Agreement on Commercial Promotion between Peru and the United States 
(Law no. 29316, 14 January 2007, in the Official Peruvian Diary) has amended the last requirement; a sanction 
exists to penalize the applicant if the requested documentation is not presented, but this is not a cause for 
annulment or invalidity of the patent application or the approved patent. 
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